Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	4 Months Ended	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2013
Operating activities:
Net income		$ 17,952
Adjustments to reconcile net income to net cash used in operating activities:
Share-based compensation	0	188
Net unrealized gain on mortgage loans	0	(25,963)
Net realized gain on mortgage loans	0	(4,015)
Real estate depreciation and amortization	0	4
Amortization of deferred financing costs	0	630
Changes in operating assets and liabilities:
Related party receivables	0	(527)
Prepaid expenses and other assets	0	(213)
Accounts payable and accrued liabilities	0	1,103
Related party payables	0	1,174
Net cash used in operating activities	0	(9,667)
Investing activities:
Investment in mortgage loans	0	(642,645)
Investment in real estate	0	(6,198)
Investment in renovations	0	(145)
Mortgage loan dispositions and payments	0	15,895
Change in restricted cash	0	(3,092)
Net cash used in investing activities	0	(636,185)
Financing activities:
Issuance of common stock, including stock option exercises	500	323,619
Cost of issuance of common stock	0	(13,441)
Dividends on common stock	0	(2,509)
Payment of tax withholdings on exercise of stock options	0	(116)
Proceeds from repurchase agreement	0	418,099
Repayments of repurchase agreement	0	(79,299)
Payment of deferred financing costs	0	(2,254)
Net cash provided by financing activities	500	644,099
Net increase/(decrease) in cash and cash equivalents	500	(1,753)
Cash and cash equivalents as of beginning of the period	0	100,005
Cash and cash equivalents as of end of the period	500	98,252
Supplemental disclosure of non-cash investing and financing activity:
Transfer of mortgage loans to real estate owned	0	10,598
Changes in accrued equity issuance costs	0	1,242
Changes in related party receivable from mortgage loan dispositions and repayments	$ 0	$ 5,745